Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | EYA2 | O00167 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.56 |
| ▸ | ACE | P12821 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | DRD1 | P21728 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | DRD3 | P35462 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29223005 | 1.00 | TDP1 (0.56) | TDP1EYA2APPACEBLM | |
| SCHEMBL16213775 | 0.98 | TDP1 (0.58) | TDP1EYA2APPACEBLM | |
| SCHEMBL8866526 | 0.96 | TDP1 (0.54) | TDP1EYA2APPACEBLM | |
| SCHEMBL11997181 | 0.94 | TDP1 (0.58) | TDP1EYA2APPACEBLM | |
| SCHEMBL9342972 | 0.92 | TDP1 (0.40) | TDP1EYA2APPACEBLM | |
| SCHEMBL12358237 | 0.83 | TDP1 (0.36) | TDP1EYA2APPACEBLM | |
| SCHEMBL345564 | 0.83 | FFAR3 (0.38) | TDP1EYA2APPACEBLM | |
| SCHEMBL22120 | 0.83 | FFAR3 (0.38) | TDP1EYA2APPACEBLM | |
| SCHEMBL6320153 | 0.83 | FFAR3 (0.38) | TDP1EYA2APPACEBLM | |
| SCHEMBL20822424 | 0.82 | TDP1 (0.62) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119487140-A | CMP slurry composition for polishing copper barrier layer | YC化工股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-11963761-B2 | Mediation of in vivo analyte signal degradation | SENSEONICS, INCORPORATED (US) | 2024-04-23 | — | — | US | claimed |
| CN-108291314-A | Copper etching composition and hydroperoxide kind metal etch composition | OCI有限公司 | 2018-07-17 | — | — | CN | claimed |
| CN-103282549-B | Composition for etching metal layers | OCI Co.,Ltd. (KR) | 2015-09-02 | — | — | CN | claimed |
| CN-103282549-A | Composition for etching metal layers | OCI CO LTD | 2013-09-04 | — | — | CN | claimed |
| WO-2012034032-A2 | ANTIMICROBIAL SOLUTIONS | THE BOARD OF REGENTS OF UNBIVERSITY OF TEXAS SYSTEM (US) | 2012-03-15 | — | — | WO | claimed |
| US-5368707-A | Electrochemistry, bioelectrode of immobilized enzyme | ANDCARE, INC. (US) | 1994-11-29 | — | — | US | claimed |
| US-20250305931-A1 | METHOD FOR ANALYZING A URINE SAMPLE, AND A REAGENT FOR ANALYZING A URINE SAMPLE | SYSMEX CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-4624926-A1 | A METHOD FOR ANALYZING A URINE SAMPLE, AND A REAGENT FOR ANALYZING A URINE SAMPLE | SYSMEX CORPORATION (JP) | 2025-10-01 | — | — | EP | disclosed |
| CN-119487140-A | CMP slurry composition for polishing copper barrier layer | YC化工股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250009940-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-01-09 | — | — | US | disclosed |
| US-20240341633-A1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | SENSEONICS, INCORPORATED (US) | 2024-10-17 | — | — | US | disclosed |
| EP-4433107-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | Board of Regents, The University of Texas System (US) | 2024-09-25 | — | — | EP | disclosed |
| US-20170050989-A1 | Molecular Imaging Probes | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2017-02-23 | — | — | US | disclosed |
| CN-103282549-B | Composition for etching metal layers | OCI Co.,Ltd. (KR) | 2015-09-02 | — | — | CN | disclosed |
| WO-2015085005-A1 | MOLECULAR IMAGING PROBES | THE GENERAL HOSPITAL CORPORATION (US) | 2015-06-11 | — | — | WO | disclosed |
| CN-103282549-A | Composition for etching metal layers | OCI CO LTD | 2013-09-04 | — | — | CN | disclosed |
| CN-102198184-A | Effect of morinda officinalis extract on improving or treating sexual disorder, and application thereof | CHENGDU YIPING MEDICAL TECHNOLOGY DEV CO LTD | 2011-09-28 | — | — | CN | disclosed |
| EP-2167166-A1 | ANTISEPTIC CAP WITH THREAD COVER | Excelsior Medical Corporation (US) | 2010-03-31 | — | — | EP | disclosed |
| WO-2009002474-A1 | ANTISEPTIC CAP WITH THREAD COVER | EXCELSIOR MEDICAL (US) | 2008-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050989-A1 | Molecular Imaging Probes | SLC10A1, CFTR, FIBP | TDP1 2926/4885EYA2 2046/4885APP 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.